I’m a radiation oncologist and
researcher with a particular interest in data
science (biostatistics, data mining/machine learning), bioinformatics,
molecular biomarkers, and radiomics. I focus on the
implementation of artificial intelligence in oncology. My clinical
interests focus on urinary (bladder, prostate) and gastrointestinal
cancers (rectal).
|
|
Employment history
- 2024 - still: Assistant Professor, Department of Biostatistics and
Translational Medicine, Medical University of Lodz, Poland
- Supervisor of the “Artificial Intelligence in Oncology” Students’
Scientific Group.
- Lecturer in Biostatistics, Translational Medicine, Research
Methodology, and AI, including data mining and deep learning.
- Engaged in cancer research, focusing on bioinformatics and omic data
analysis (radiomics, NGS sequencing - miRNA-seq, bulk/sc RNA-seq,
WXS).
- PI in ERA PerMed Consortium.
- 2023 - still: Radiation Oncologist, Deputy
Head of Deprtment of Brachytherapy and General Oncology, Regional Oncology Centre,
Copernicus Memorial Hospital, Lodz, Poland
- Deputy supervisor of a 26-bed ward, managing treatments like
radiation (both external beam RT and brachytherapy), chemoradiotherapy,
chemotherapy, and immunotherapy.
- Actively treating patients with various types of cancer,
specializing in urological, gastrointestinal, and lung cancers (see https://radioonkolog.pl for clinical
activities). SI in clinical trials.
- 2022 - still: Research Fellow in Radiation Oncology
(Mouw Lab and
Carvalho Lab),
Dana-Farber Cancer Institute/Harvard Medical School/Broad Institute of
MIT and Harvard, Boston, MA, USA
- 2021 - 2023: Research and Teaching Assistant, Department of Biostatistics and
Translational Medicine, Medical University of Lodz, Poland
- 2018 - 2023: Radiation Oncology Resident Physician,
Regional Oncology Centre,
Copernicus Memorial Hospital, Lodz, Poland
- Physician in Department of Radiotherapy and on-call physician in
Radiotherapy and Oncology Ward (reference: Prof. Jacek Fijuth, M.D.,
Ph.D.),
- Additional experience as on-call physician in Hematooncology Ward
(reference: Prof. Piotr Smolewski, M.D., Ph.D.).
- 2017 - 2018: Bioinformatics and Medical Informatics
Specialist, Department of
Biostatistics and Translational Medicine, Medical University of
Lodz, Poland
- 2016 - 2017: Medical Post-graduate Internship, Clinical Hospital of the Ministry of
the Interior and Administration in Lodz, Lodz, Poland
Education
- 2023: Board Certification (Radiation Oncology),
Medical Examinations Center (CEM) in Poland;
- 2016 - 2021: Doctor of Philosophy (PhD)
(doctorate), Department of Biostatistics and Translational Medicine
(reference: Wojciech Fendler, M.D., Ph.D.; https://biostat.umed.pl):
- 2017: Obtaining the full medical license in Poland (PWZ:
3347648)
- 2010 - 2016: Doctor of Medicine (MD) (6-year
M.D. Program; grade: very good), Faculty
of Medicine, Medical University of Lodz (Poland)
Internships
- 2022-2023: Bekker NAWA (6 months) research fellowship in Dana-Farber
Cancer Institute/Harvard Medical School/Broad Institute of MIT and
Harvard, Boston, MA, USA (reference: Kent Mouw, M.D., Ph.D.)
- 2016: ERAMSUS+ research internship at EPSRC Centre For Mathematical
And Statistical Analysis Of Multimodal Clinical Imaging, University of
Cambridge, Cambridge, UK (reference: Prof. John Aston, Ph.D.)
- 2015: IFMSA research exchange (6 weeks), Psychiatric Genetic
Epidemiology & Neurobiology Laboratory (PsychGENe Lab), Upstate
Medical University, Syracuse, NY, USA (reference: Stephen J. Glatt,
Ph.D.)
- 2014: neurosurgical clinical clerkship (3 weeks), University
Hospital Southampton NHS Trust, Southampton, UK (reference: Paul Grundy,
M.D.)
- 2013: medical clinical clerkship (4 weeks), Mubarak Al Kabeer
Hospital, Kuwait City, Kuwait (reference: Ibrahim T. Lasheen, M.D.)
Funded research
projects
- 2023 - still: ERA
PerMed Consortium (Joint Transnational Call 2022), miRPOC - miRNA as
biomarkers in early detection and personalised treatment in ovarian
cancer, ~1 000 000 EUR [Partner PI at Medical
University of Lodz; consortium with Cancer Registry of Norway/Oslo
University Hospital, German Cancer Research Center and Brigham and
Women’s Hospital/Harvard Medical School]
- 2019 - 2022: NCN PRELUDIUM [ID:
UMO-2018/29/N/NZ5/02422
], Deep artificial neural networks
in the integration of the expression profile of circulating and
intracellular miRNA molecules in pancreatic cancer patients., 209 860
PLN [PI]
- 2014 - 2015: Ministry of the Interior Generation of the Future [ID:
MNiSw/2014/DIR/379/GPII
], PancreApp: application of the
eight-dimensional Shepard approximation in the individualization of
nutritional recommendations, with particular emphasis on chronic
pancreatitis, PLN 37,800 [PI]
- 2017 - 2018: Specialist in bioinformatics and medical informatics
(building an internet platform to collect data for the research purposes
of the project) in the project “Lodz Program for HNSCC Prevention” [ID:
POWR.05.01.00-00-0011/16
] co-financed by the European Union
as part of the European Social Fund (European Social Fund, 1 792 260
PLN) 2019-2021: Researcher in the study “Predictive Biomarkers of
Radiation Toxicity (PBRTox)” [ID: POIR.04.04.00-00-2280/16
]
under the supervision of prof. Wojciech Fendler (Foundation for Polish
Science; 1 999 651 PLN) 2014-2016: Researcher in the study “Profile of
circulating microRNAs in the diagnosis of rare forms of diabetes” [ID:
2012/05/E/NZ5/02130
] under the supervision of prof.
Wojciech Fendler (NCN SONATA BIS; 1 489 800 PLN)
Patents and
commercializations
- CA3223723A1, entitled “Circulating microrna signatures for
pancreatic cancer”
- EP3565903 and US20200123614A1, entitled “CIRCULATING MICRORNA
SIGNATURES FOR OVARIAN CANCER”; commercialized (license agreement
A15876-ELA-ASPIRA with Aspira Women Health)
Selected awards and
scholarships
- 2022: Best biostatistics Ph.D. thesis in 2021 (Awarded by StatSoft
Polska).
- 2022: Implementation Activity Award of Polish Ministry of Science,
for work involving the implementation of a diagnostic tests based on
free-circulating microRNAs into clinical practice.
- 2021: Scholarship of Polpharma Scientific Foundation for best
Ph.D. students.
- 2020: Scholarship for the best Ph.D. students at the Medical
Univeristy of Lodz.
- 2019: Scholarship for the best Ph.D. students at the Medical
Univeristy of Lodz.
- 2018: Scholarship for the best Ph.D. students at the Medical
Univeristy of Lodz.
- 2017: Scholarship for the best Ph.D. students at the Medical
Univeristy of Lodz.
- 2016: Scholarship for the best Ph.D. students at the Medical
Univeristy of Lodz.
- 2016: Scholarship of the City of Lodz for the best
Ph.D. students.
- 2016: Winner of Adzduna’s polish „Graduate of the Year”
contest.
- 2015: Scholarship of Minister of Science and Higher Education &
Minister of Health of Republic of Poland for outstanding achievements
for students in the academic year 2015/2016.
- 2015: Scholarship of Marshal of the Lodzkie Region (highest
degree)
- 2014: Distinction in a nationwide competition “Studencki Nobel”
(Eng. “Student’s Nobel Prize”).
- 2014: Special Award for the Youngest Winner of the Session at the
conference 10. International & 52. Polish Training & Scientific
Medical Congress of Students’ Scientific Societies and Junior Doctors
“Juvenes Pro Medicina” 2014 in Łódź (founder: Aldona Ochęcka-Szymańska
M.D., Ph.D.)
- 2013: Scholarship of Minister of Science and Higher Education of
Republic of Poland for outstanding achievements for students in the
academic year 2013/2014;
Research
Bibliometrics
H-index according to Google Scholar: 14
(citations = 672;
papers/abstracts = 72)
Research papers
- A Puła, T Robak, I Dróżdż, K Stawiski, A Rycerz, M Misiewicz, P
Robak Circulating serum microRNAs as biomarkers of drug
resistance in multiple myeloma patients treated with bortezomib-based
regimens–pilot study Leukemia & Lymphoma
2024:65 (2), 257-264 [citations: 1]
- Z Nowicka, K Kuna, M Łaszczych, M Łazar-Poniatowska, BK Sobocki, …
Dose-volume metric-based prediction of radiotherapy-induced
lymphocyte loss in patients with non-small-cell lung cancer treated with
modern radiotherapy techniques Physics and Imaging in
Radiation Oncology 2024:100593 [citations: 0]
- BA Łochowska, K Stawiski, K Kuna, Z Nowicka, M Lochowski, J Fijuth
Predicting of overall survival in non-small cell lung cancer
patients receiving concurrent radiochemotherapy and adjuvant
durvalumab–a Polish real-world single-center experience
Nowotwory. Journal of Oncology 2024:
[citations: 0]
- D Mikulski, M Nowicki, I Dróżdż, E Perdas, P Strzałka, K Kościelny,
… MicroRNAs predict early complications of autologous
hematopoietic stem cell transplantation Biomarker Research
2024:12 (1), 42 [citations: 0]
- P Brady, A Yousif, N Sasamoto, AF Vitonis, W Fendler, K Stawiski, …
Plasma microRNA expression in adolescents and young adults with
endometriosis: the importance of hormone use Frontiers in
Reproductive Health 2024:6, 1360417 [citations:
0]
- F Mohammed, K Stawiski, HS Musa, SK Owolabi, S Abubakar, SO Rotimi,
… Co-expression of HERV-R, CCND1, BRAF, FOXA1, TMPRSS2, ATF4 and
low expression of BAZ1B and KMT2D is associated with early detection and
poor prognosis of prostate cancer in … Cancer Research
2024:84 (6_Supplement), 6432-6432 [citations:
0]
- FLF De Carvalho, J Lee, K Bi, B Titchen, K Stawiski, J Park, A
Garza, … Tumor-immune interactions and cisplatin resistance in
localized muscle-invasive bladder cancer Cancer Research
2024:84 (6_Supplement), 7041-7041 [citations:
0]
- Z Nowicka, K Kuna, K Stawiski, J Sołek, M Świderek, A Papis‐Ubych, …
Extreme acute radiation‐induced toxicity in a patient with
polymorphous low‐grade adenocarcinoma of the nasopharynx and rare
variants in DNA repair genes Head & Neck
2024:46 (2), E10-E17 [citations: 0]
- K Elias, U Smyczynska, K Stawiski, Z Nowicka, J Webber, J Kaplan, …
Identification of BRCA1/2 mutation female carriers using
circulating microRNA profiles Nature Communications
2023:14 (1), 3350 [citations: 7]
- Z Nowicka, B Tomasik, D Kozono, K Stawiski, T Johnson, D Haas-Kogan,
… Serum miRNA-based signature indicates radiation exposure and
dose in humans: a multicenter diagnostic biomarker study
Radiotherapy and Oncology 2023:185, 109731
[citations: 4]
- Y Zhou, J Börcsök, E Adib, SC Kamran, AJ Neil, K Stawiski, D
Freeman, … ATM deficiency confers specific therapeutic
vulnerabilities in bladder cancer Science advances
2023:9 (47), eadg2263 [citations: 3]
- J Malinowski, W Pietruszewska, K Stawiski, M Kowalczyk, M Barańska,
… High-speed videoendoscopy enhances the objective assessment of
glottic organic lesions: a case-control study with multivariable
data-mining model development Cancers
2023:15 (14), 3716 [citations: 2]
- M Miszczyk, Ł Magrowski, T Krzysztofiak, R Stando, W Majewski, …
Brachytherapy boost improves survival and decreases risk of
developing distant metastases compared to external beam radiotherapy
alone in intermediate and high risk group … Radiotherapy
and Oncology 2023:183, 109632 [citations: 2]
- D Chowdhury, KM Elias, W Fendler, K Stawiski Circulating
microrna signatures for ovarian cancer US Patent App.
2023:17/810,495 [citations: 0]
- K Stawiski, J Perera-Bel, A Rodriguez-Vida, NJ Rodero, KW Mouw, …
Assessing tumor-infiltrating immune cells and outcomes with
cisplatin-versus carboplatin-based treatment in advanced urothelial
cancer (UC): Survival analysis of three platinum … Journal
of Clinical Oncology 2023:41 (16_suppl), 4583-4583
[citations: 0]
- M Masłowski, K Stawiski, A Zięba, D Mikulski, J Bednarek, J Fijuth
Predicting neutropenia dynamics after radiation therapy in
multiple myeloma patients receiving first-line bortezomib-based
chemotherapy–a pilot study Biuletyn Polskiego Towarzystwa
Onkologicznego Nowotwory 2023:8 (4), 274-283
[citations: 0]
- M Jobczyk, K Stawiski, M Kaszkowiak, P Rajwa, W Różański, F Soria, …
Deep Learning-based Recalibration of the CUETO and EORTC
Prediction Tools for Recurrence and Progression of Non–muscle-invasive
Bladder Cancer European urology oncology
2022:5 (1), 109-112 [citations: 19]
- K Mieczkowski, K Kitowska, M Braun, B Galikowska‐Bogut, …
FGF7/FGFR2–JunB signalling counteracts the effect of
progesterone in luminal breast cancer Molecular oncology
2022:16 (15), 2823-2842 [citations: 9]
- K Stawiski, M Kaszkowiak, D Mikulski, P Hogendorf, A Durczyński, …
OmicSelector: automatic feature selection and deep learning
modeling for omic experiments BioRxiv
2022:2022.06. 01.494299 [citations: 9]
- Ł Kuncman, M Orzechowska, K Stawiski, M Masłowski, M Ciążyńska, …
The kinetics of FMS-related tyrosine kinase 3 ligand (Flt-3L)
during chemoradiotherapy suggests a potential gain from the earlier
initiation of immunotherapy Cancers
2022:14 (16), 3844 [citations: 7]
- M Panek, K Stawiski, M Kaszkowiak, P Kuna Cytokine TGFβ gene
polymorphism in asthma: TGF-related SNP analysis enhances the prediction
of disease diagnosis (a case-control study with multivariable
data-Mining model … Frontiers in Immunology
2022:13, 746360 [citations: 7]
- M Miszczyk, J Rembak-Szynkiewicz, Ł Magrowski, K Stawiski, …
The prognostic value of PI-RADS score in CyberKnife
ultra-hypofractionated radiotherapy for localized prostate
cancer Cancers 2022:14 (7), 1613
[citations: 4]
- EJ Bobeff, M Bukowiecka-Matusiak, K Stawiski, K Wiśniewski, …
Plasma amino acids may improve prediction accuracy of cerebral
vasospasm after aneurysmal subarachnoid haemorrhage Journal
of Clinical Medicine 2022:11 (2), 380 [citations:
4]
- A Gockley, K Pagacz, S Fiascone, K Stawiski, N Holub, K Hasselblatt,
… A translational model to improve early detection of epithelial
ovarian cancers Frontiers in Oncology
2022:12, 786154 [citations: 3]
- W Fendler, B Tomasik, K Atkins, K Stawiski, J Chałubińska-Fendler, …
The clinician’s guide to radiotherapy complications
Polskie Archiwum Medycyny Wewnętrznej 2022:132
(1) [citations: 2]
- M Miszczyk, E Staniewska, I Jabłońska, A Lipka-Rajwa, K Stawiski, …
Volumetric staging in radiotherapy for oropharyngeal
cancers Tumori Journal 2022:108 (6),
586-591 [citations: 0]
- K Stawiski, M Maslowski, W Maslowska, M Kordzinska, B Lochowska, …
Clinical and Radiomics-Based Deep Learning Predictive Model for
Early Treatment Failure after Neoadjuvant Radiochemotherapy for Rectal
Cancer International Journal of Radiation Oncology,
Biology, Physics 2022:114 (3), e150 [citations:
0]
- M Miszczyk, J Ciepał, R Stando, O Masri, I Jabłońska, K Stawiski, …
The Association between Dose Escalation and Risk of Developing
Metastases in Intermediate and High-Risk Prostate Cancer Patients
Treated with Radiotherapy International Journal of
Radiation Oncology, Biology, Physics 2022:114 (3),
e231 [citations: 0]
- A Napieralska, J Bochenek-Cibor, A Chyrek, M Konkol, E Pawłowska, …
Improving Education in Radiation Oncology in Poland
International Journal of Radiation Oncology, Biology, Physics
2022:114 (1), e4-e5 [citations: 0]
- S Kubik, D Jesionek-Kupnicka, K Stawiski, J Fijuth, …
Clinical significance of CD34, podoplanin and Ki-67 expression
in patients with locally advanced squamous cell cervical
carcinoma Journal of Obstetrics and Gynaecology
2022:42 (6), 2248-2254 [citations: 0]
- D Mikulski, M Nowicki, I Dróźdż, E Perdas, P Strzałka, K Kościelny,
… Serum miRNA-based neural network models for predicting
complications in patients receiving high-dose melphalan or BeEAM
conditioning chemotherapy. Acta Haematologica Polonica
2022:53 [citations: 0]
- EJ Bobeff, K Stawiski, PA Stanisławska, BJ Posmyk, K Wiśniewski, M
Bryl, … Validation of the Elderly Traumatic Brain Injury Score:
Observational Case Control Study World neurosurgery
2022:161, e464-e472 [citations: 0]
- D Chowdhury, KM Elias, W Fendler, K Stawiski Circulating
microRNA signatures for ovarian cancer US Patent
2022:11,214,839 [citations: 0]
- M Panek, K Stawiski, M Kaszkowiak, P Kuna Cytokine TGFβ gene
polymorphisms in asthma Frontiers in Immunology
2022:13 [citations: 0]
- EJ Bobeff, M Bukowiecka-Matusiak, K Stawiski, K Wisniewski, …
Kordzi nska J. Clin. Med 2022:11,
380 [citations: 0]
- B Tomasik, A Papis-Ubych, K Stawiski, J Fijuth, P Kędzierawski, …
Serum MicroRNAs as xerostomia biomarkers in patients with
oropharyngeal cancer undergoing radiation therapy
International Journal of Radiation Oncology Biology* Physics
2021:111 (5), 1237-1249* [citations: 13]
- P Robak, D Jarych, D Mikulski, I Dróżdż, E Węgłowska, A Kotkowska, …
The prognostic value of whole-blood PSMB5, CXCR4, POMP, and RPL5
mRNA expression in patients with multiple myeloma treated with
bortezomib Cancers 2021:13 (5), 951
[citations: 11]
- P Michał, S Konrad, K Piotr TGF-β gene polimorphisms as risk
factors for asthma control among clinic patients Journal of
Inflammation 2021:18, 1-12 [citations: 5]
- L Lee, B Howitt, T Cheng, M King, K Stawiski, W Fendler, D
Chowdhury, … MicroRNA profiling in a case-control study of
African American women with uterine serous carcinoma
Gynecologic Oncology 2021:163 (3), 453-458
[citations: 4]
- D Mikulski, I Dróżdż, E Perdas, K Stawiski, M Nowicki, M Misiewicz,
… Changes in the microrna expression profile in patients
undergoing autologous steam cell transplantation Blood
2021:138, 4789 [citations: 4]
- M Miszczyk, W Majewski, K Stawiski, K Rasławski, P Rajwa, I
Jabłońska, … Prognostic factors in postoperative radiotherapy
for prostate cancer–tertiary center experience Radiology
and Oncology 2021:55 (2), 203-211 [citations:
2]
- Z Nowicka, R Bibik, R Stando, W Fendler, K Stawiski, B Tomasik
A link between seasonality and radiation-related toxicity: The
big time or time will tell? Radiotherapy and Oncology
2021:161, 257-258 [citations: 1]
- ES Komseli, IS Pateras, T Krejsgaard, K Stawiski, SV Rizou, A
Polyzos, … A prototypical non-malignant epithelial model to
study genome dynamics and concurrently monitor micro-RNAs and proteins
in situ during oncogene-induced senescence (vol 19, 37 …
BMC GENOMICS 2021:22 (1) [citations: 0]
- ES Komseli, IS Pateras, T Krejsgaard, K Stawiski, SV Rizou, A
Polyzos, … Correction to: A prototypical non-malignant
epithelial model to study genome dynamics and concurrently monitor
micro-RNAs and proteins in situ during oncogene-induced
senescence BMC genomics 2021:22
[citations: 0]
- B Małachowska, B Tomasik, K Stawiski, S Kulkarni, C Guha, …
Circulating microRNAs as biomarkers of radiation exposure: A
systematic review and meta-analysis International Journal
of Radiation Oncology Biology* Physics 2020:106
(2), 390-402* [citations: 46]
- M Jobczyk, K Stawiski, W Fendler, W Różański Validation of
EORTC, CUETO, and EAU risk stratification in prediction of recurrence,
progression, and death of patients with initially non–muscle‐invasive
bladder cancer (NMIBC … Cancer Medicine
2020:9 (11), 4014-4025 [citations: 33]
- P Robak, I Dróżdż, D Jarych, D Mikulski, E Węgłowska, M
Siemieniuk-Ryś, … The value of serum microRNA expression
signature in predicting refractoriness to bortezomib-based therapy in
multiple myeloma patients Cancers 2020:12
(9), 2569 [citations: 20]
- Ł Kuncman, K Stawiski, M Masłowski, J Kucharz, J Fijuth
Dose–volume parameters of MRI-based active bone marrow predict
hematologic toxicity of chemoradiotherapy for rectal cancer
Strahlentherapie und Onkologie 2020:196,
998-1005 [citations: 16]
- M Braun, D Piasecka, B Tomasik, K Mieczkowski, K Stawiski, A
Zielinska, … Hormonal receptor status determines prognostic
significance of FGFR2 in invasive breast carcinoma Cancers
2020:12 (9), 2713 [citations: 10]
- Z Nowicka, B Tomasik, DE Kozono, K Stawiski, TJ Johnson, …
Serum Circulating MicroRNAs as Functional Biodosimeters in
Patients Undergoing Total Body Irradiation International
Journal of Radiation Oncology, Biology, Physics
2020:108 (3), e536 [citations: 0]
- Z Nowicka, K Stawiski, B Tomasik, W Fendler Extracellular
miRNAs as biomarkers of head and neck cancer progression and
metastasis International journal of molecular sciences
2019:20 (19), 4799 [citations: 37]
- A Zmyslowska, A Waszczykowska, D Baranska, K Stawiski, M Borowiec, …
Optical coherence tomography and magnetic resonance imaging
visual pathway evaluation in Wolfram syndrome Developmental
Medicine & Child Neurology 2019:61 (3),
359-365 [citations: 21]
- EJ Bobeff, J Fortuniak, B Bryszewski, K Wiśniewski, M Bryl, K
Kwiecień, … Mortality after traumatic brain injury in elderly
patients: a new scoring system World neurosurgery
2019:128, e129-e147 [citations: 20]
- M Kotlicka-Antczak, MS Karbownik, K Stawiski, A Pawełczyk, N Żurner,
… Short clinically-based prediction model to forecast transition
to psychosis in individuals at clinical high risk state
European Psychiatry 2019:58, 72-79 [citations:
18]
- M Zakrzewska, R Gruszka, K Stawiski, W Fendler, J Kordacka, …
Expression-based decision tree model reveals distinct microRNA
expression pattern in pediatric neuronal and mixed neuronal-glial
tumors BMC cancer 2019:19, 1-11
[citations: 11]
- EJ Bobeff, BJ Posmyk, K Bobeff, J Fortuniak, K Wiśniewski, K
Stawiski, … Predicting outcome and conservative treatment
failure in patients with skull fracture after traumatic brain injury: a
retrospective cohort study Journal of Neurological Surgery
Part A: Central European Neurosurgery 2019:80
(06 … [citations: 3]
- L Kuncman, K Stawiski, M Maslowski, J Wilczynska, J Bury, J Fijuth
FT3-L Dynamics in Blood Could be Predictive of Time of
Occurrence Lymphocyte Nadir in Patients Undergoing Preoperative
Chemoradiotherapy for Rectal Cancer. International Journal
of Radiation Oncology, Biology, Physics 2019:105 (1),
E167-E168 [citations: 0]
- ES Komseli, IS Pateras, T Krejsgaard, K Stawiski, SV Rizou, A
Polyzos, … A prototypical non-malignant epithelial model to
study genome dynamics and concurrently monitor micro-RNAs and proteins
in situ during oncogene-induced … BMC genomics
2018:19, 1-22 [citations: 51]
- K Pagacz, K Stawiski, A Szadkowska, W Mlynarski, W Fendler
GlyCulator2: an update on a web application for calculation of
glycemic variability indices Acta diabetologica
2018:55, 877-880 [citations: 33]
- A Puła, K Stawiski, M Braun, E Iskierka-Jażdżewska, T Robak
Efficacy and safety of B-cell receptor signaling pathway
inhibitors in relapsed/refractory chronic lymphocytic leukemia: a
systematic review and meta-analysis of randomized …
Leukemia & Lymphoma 2018:59 (5), 1084-1094
[citations: 19]
- K Stawiski, I Pietrzak, W Młynarski, W Fendler, A Szadkowska
NIRCa: An artificial neural network‐based insulin resistance
calculator Pediatric diabetes 2018:19 (2),
231-235 [citations: 14]
- KM Elias, W Fendler, K Stawiski, SJ Fiascone, AF Vitonis, RS
Berkowitz, … Diagnostic potential for a serum miRNA neural
network for detection of ovarian cancer Elife
2017:6, e28932 [citations: 143]
- J Trelinska, I Dachowska, D Baranska, K Stawiski, K Kotulska, W
Fendler, … Maintenance therapy with everolimus for subependymal
giant cell astrocytoma in patients with tuberous sclerosis (the EMINENTS
study) Pediatric blood & cancer
2017:64 (6), e26347 [citations: 26]
- K Stawiski, J Trelińska, D Baranska, I Dachowska, K Kotulska, S
Jóźwiak, … What are the true volumes of SEGA tumors? Reliability
of planimetric and popular semi-automated image segmentation
methods Magnetic Resonance Materials in Physics, Biology
and Medicine 2017:30, 397-405 [citations: 7]
- KM Elias, W Fendler, K Stawiski, SJ Fiascone, AF Vitonis, RS
Berkowitz, … Diagnostic potential for a serum miRNA neural
network for detection of ovarian cancer. Elife eLife
Sciences Publications Limited 2017:6, e28932
[citations: 5]
- A Pula, K Stawiski, M Braun, E Iskierka-Jazdzewska, T Robak
A systematic review and meta-analysis of B-cell receptor
signaling inhibitors in relapsed and refractory chronic lymphocytic
leukemia LEUKEMIA & LYMPHOMA 2017:58,
152-153 [citations: 0]
- M Zakrzewska, W Fendler, K Stawiski, R Gruszka, K Zakrzewski, …
Comparative Analysis of miRNA Expression in Pediatric Neuronal
and Mixed Neuronal-Glial Tumors PEDIATRIC BLOOD &
CANCER 2017:64, S318-S318 [citations: 0]
- LJ Lee, BE Howitt, W Fendler, K Stawiski, P Bu, L Cho, D Chowdhury,
… miRNA profiling in a case: Control study of African American
women with uterine serous carcinoma (USC). Journal of
Clinical Oncology 2017:35 (15_suppl),
e17116-e17116 [citations: 0]
- KM Elias, WF Fendler, K Stawiski, A Vitonis, RS Berkowitz, DW
Cramer, … Serum MicroRNA Sequencing for Early Diagnosis of
Invasive Ovarian Cancer. REPRODUCTIVE SCIENCES
2017:24, 87A-87A [citations: 0]
- Ł Dziki, A Puła, K Stawiski, B Mudza, M Włodarczyk, A Dziki
Patients’ awareness of the prevention and treatment of
colorectal cancer Polish Journal of Surgery
2015:87 (9), 459-463 [citations: 14]
- K Stawiski, A Strzałka, A Puła, K Bijakowski PancreApp: An
Innovative Approach to Computational Individualization of Nutritional
Therapy in Chronic Gastrointestinal Disorders MEDINFO
2015:2015: eHealth-enabled Health, 325-328
[citations: 2]
- K Elias, U Smyczynska, K Stawiski, Z Nowicka, J Webber, J Kaplan, …
Identification of BRCA1/2 mutation female carriers using
circulating microRNA pro les screening
NA:10, 1 [citations: 0]
See the details on PubMed: http://link.konsta.com.pl/pubmed
Not-indexed conference posters and awards were not included here.
Book chapters
- Konrad Stawiski, Łukasz Polak, Wojciech Fendler, Jarosław Drożdż.
Evidence-based medicine w kardiologii. WIELKA INTERNA: Kardiologia część
1 - wydanie II. Medical Tribune Polska 2018.
- Konrad Stawiski, Jacek Fijuth. Sztuczna inteligencja w onkologii.
Innowacyjna Onkologia: potrzeby, możliwości, system. PZWL 2020. ISBN
978-83-200-6032-4
Teaching and invited
lectures
- 2023: “Odmienne twarze Greja – dawki biologicznie równoważne w
zależności od sposobu frakcjonowania i lokalizacji anatomicznej”.
Konferencja “Radioterapia stereotaktyczna w dobie leczenia celowanego”
[Polish]
- 2023: “Wyniki badania klinicznego – analiza oraz ocena wartości”
(Clinical trial results - analysis and value assessment) as part of the
postgraduate studies “Non-commercial Clinical Research - Design,
Implementation and Management” (Wroclaw Medical University)
- 2022: “Czy sztuczna inteligencja zastąpi człowieka w planowaniu
leczenia promieniami? (Will artificial intelligence replace humans in
radiation treatment planning?)”, X Zjazd Polskiego Towarzystwa
Radioterapii Onkologicznej, Łódź
- 2022: “Deep artificial neural networks in the integration of the
expression profile of circulating and intracellular miRNA particles in
pancreatic cancer patients.” Lodz Oncology Days
- 2022: “Application of advanced statistical tools and artificial
intelligence in prognosis and response prediction to treatment in
prostate cancer”. Rak Stercza - Wielodyscyplinarne Podejście Do Terapii
Po Niepowodzeniu Leczenia Miejscowego I W Chorobie Z Przerzutam
- 2022: “Time series analysis” as part of postgraduate studies
“Elements of empirical research methodology in medicine and application
of statistics in biomedical research” (Medical University of Lodz)
- 2022: “Introduction to Data Mining methods and the STATISTICA Data
Mininer system” as part of postgraduate studies “Elements of empirical
research methodology in medicine and the application of statistics in
biomedical research” (Medical University of Lodz)
- 2021-2022: “Data in clinical trials (CRF) and database management.”
as part of the postgraduate studies “Non-commercial Clinical Research -
Design, Implementation and Management” (Wroclaw Medical University)
- 2021-2022: “New Technologies in Clinical Trials. Big Data.” as part
of postgraduate studies “Non-commercial clinical research - design,
implementation and management” (Medical University in Wrocław)
- 2021: “Biostatistics workshops” as part of the initiative of the
Young Division of the Polish Society of Radiation Oncology
- 2019: “Deep teaching as a technique to increase the effectiveness of
molecular biomarkers” 9th Congress of the Polish Society of Radiation
Oncology
- 2018: “Data mining to discover ovarian cancer signature in the miRNA
serum profile” Elias Lab Meeting at Brigham and Women’s Hospital,
Dana-Farber Cancer Institute, Boston, USA
- 2018: “From anatomy to artificial intelligence in oncology” Local
“I’m gonna be a scientist” conference.
Commercial clinical
trials
Own open source IT
projects
Certified
courses
- 2022: Single-cell RNA-seq data analysis workshop, Harvard Chan
Bioinformatics Core (HBC), Boston, MA, USA
- 2022: Bulk RNA-seq data analysis workshop (part 1 and 2), Harvard
Chan Bioinformatics Core (HBC), Boston, MA, USA
- 2016: “Computational Genomics” (Summer School), Max-Delbrück-Centre
for Molecular Medicine, Berlin, Germany
- 2016: “Fundamentals of Digital Image and Video Processing” (Coursera
ID: ULTLWMZSCYEZ), Northwestern University , Evanston, IL, USA
Skills
- Programming: R (advanced; data processing, statistical analysis,
application programming, data mining), python (basic; data mining), C #
.NET (advanced; C # .NET WinForms desktop applications), PHP
(intermediate; website development websites using CMS Wordpress,
creating applications using Boostrap)
- Bioinformatics and medical informatics. In particular, analysis of
next-generation sequencing data and other large-scale data.
- Data analysis (data science and bioistatistics; knowledge of
STATSTICA, MedCalc, IBM SPSS; data mining using R and python and
Weka)
- Medical image analysis (knowledge of 3D Slicer, ITK SNAP,
pyRadiomics)
- Linux knowledge with server configuration: knowledge of bash;
docker; services (apache2/nginx, php, e-mail, ftp); cybersecurity - SSH
tunneling, ufw, fail2ban.
- The basics of Windows Server configuration.
Organizational
activity
- 2021 - still: Member of ESTRO (European SocieTy for Radiotherapy and
Oncology);
- 2019 - still: Member of the Polish Oncological Society;
- 2019 - still: Member of the Polish Society of Radiation
Oncology;
- 2017 - 2018: Member of the program council, Kuznia Młodych Talenty,
Academy of Young Scholars of the Polish Academy of Sciences.
- 2014 - 2016: Individual Course of Studies at the Department of
Biostatistics and Translational Medicine; tutor: Dr Wojciech
Fendler;
- 2013 - 2015: President of the Student Scientific Society of
the Medical University of Lodz.
- 2012 - 2013: Member of the Board of the Student Scientific Society
of the Medical University of Lodz.
- 2012 - 2013: Individual Course of Studies at the Department of
Neurosurgery and Oncology of the Nervous System; tutor: Dr Krzysztof
Tybor;
- 2012 - 2015: Member of the Student Scientific Society at the
Department of Neurosurgery;
- 2011 - 2015: Member of the Student Research Group at the Faculty of
Normal and Clinical Anatomy;
- 2011 - 2015: International Association of Medical Students (IFMSA):
(1) 2014: European Regional Meeting of Medicine Students, General
Delegate of Poland, (2) 2013 - 2016: IFMSA New Technologies Support
Division Director Assistant (international position), (3) 2013 - 2015:
Member of the IFMSA-Poland marketing team (national position), (4) 2013
- 2015: IFMSA-Poland National New Technologies Director (national
position), (5) 2012 - 2013: IFMSA-Poland National New Technologies
Director Assistant (national position), (6) 2012 - 2013: Local
coordinator of the project “Dying - a human thing” (local position), (7)
2011 - 2014: Local New Technologies Director (local position), (8)
participation in 3 national IFMSA-Poland assemblies (Fall 2012, Spring
2012, Fall 2013).
This CV was generated on 2024-07-09.
Copyright © 2022 Konrad Stawiski (konrad@konsta.com.pl; konrad@stawiski.net). Built as OmicApp by Konrad Stawiski.